Sanofi
HEVA Business Partner, Dupixent
Sanofi, Cambridge, Maryland, United States, 21613
HEVA Business Partner, Dupixent
ApplyLocations: Cambridge, MATime Type: Full timePosted on: Posted 2 Days AgoJob Requisition ID: R2755346About the JobWe are an innovative global healthcare company, committed to transforming the lives of people with immune challenges, rare diseases, blood disorders, cancers, and neurological disorders. From R&D to sales, our talented teams work together, revolutionizing treatment, continually improving products, understanding unmet needs, and connecting communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.Our Team:You will work in the Dupixent & Itepekimab team of the Health Economics and Value Assessment (HEVA) department. The HEVA department gathers a wealth of expertise including experts in Health Economic and Outcomes Research (HEOR), Indirect Treatment Comparison & Network Meta Analysis (ITC/NMA), Modeling, Health Technology Assessment (HTA), Epidemiology, Biostatistics, and generation of Real World Evidence (RWE).Within HEVA Dupixent & Itepekimab, you will join a team of 10 business partners, all responsible to manage HEVA projects for the indications they are leading.Dupixent is the flagship of Sanofi Specialty Care life-changing immunology franchise. It is currently being launched worldwide in atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, Chronic Obstructive Pulmonary Disease (COPD), and prurigo nodularis and has the ambition of becoming the treatment of choice for all Type 2 inflammation diseases due to its innovative mode of action. The portfolio for this product includes over 10 possible indications that are currently being evaluated at various stages of development.Itepekimab is expected to bring new treatment options for patients with COPD or with Bronchiectasis, as well as other indications currently being evaluated.Main Responsibilities:This role will be responsible for the design and execution of Health Economic and Outcomes Research (HEOR) research in the forms of economic modeling, database analysis, observational research, Clinical Outcomes Assessment (COA) development and validation, systematic literature review, evidence synthesis, value dossier development, and other types of HEOR.This role will set the HEOR evidence generation priorities for Dupixent indications under development and incorporate them into broader Sanofi planning documents such as the integrated evidence generation plan (IEGP).This role will operate as part of a multi-functional global development team that is responsible for designing clinical research programs to meet the evidentiary standards of regulators, HTA organizations, reimbursement authorities, third-party payers, and other organizations that review evidence relevant to Sanofi medicines.About YouExperience : 5 years of experience in health economics, outcomes research, or a related field.Soft Skills :
Strong communication skills, both verbal and written, including presentation skills. Significant experience making presentations to senior management is preferred. Publication in peer-reviewed journals.Strong ability to partner with HEVA colleagues and other (i.e., non-HEOR) functional areas.Entrepreneurial, team spirit, and ability to develop creative solutions to complex problems.
Technical Skills :
Demonstrated experience in applying various HEOR methods. Understanding the principles of evidence-based medicine and clinical research.Knowledge of global HTA processes and guidelines; experience with HTA submissions preferred.Understanding of the legal and regulatory environment of the pharmaceutical industry, demonstrated integrity on work-related compliance considerations, and solid ethics.
Education : Advanced degree (PhD, MD, MS, MPH, or PharmD) in a scientific discipline.Languages : English fluent, both written and oral.Why Choose UsBring the miracles of science to life alongside a supportive, future-focused team.Discover endless opportunities to grow your talent and drive your career, whether it’s through a promotion or lateral move, at home or internationally.Enjoy a thoughtful, well-crafted rewards package that recognizes your contribution and amplifies your impact.Take good care of yourself and your family, with a wide range of health and wellbeing benefits including high-quality healthcare, prevention and wellness programs, and at least 14 weeks’ gender-neutral parental leave.Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
#J-18808-Ljbffr
ApplyLocations: Cambridge, MATime Type: Full timePosted on: Posted 2 Days AgoJob Requisition ID: R2755346About the JobWe are an innovative global healthcare company, committed to transforming the lives of people with immune challenges, rare diseases, blood disorders, cancers, and neurological disorders. From R&D to sales, our talented teams work together, revolutionizing treatment, continually improving products, understanding unmet needs, and connecting communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.Our Team:You will work in the Dupixent & Itepekimab team of the Health Economics and Value Assessment (HEVA) department. The HEVA department gathers a wealth of expertise including experts in Health Economic and Outcomes Research (HEOR), Indirect Treatment Comparison & Network Meta Analysis (ITC/NMA), Modeling, Health Technology Assessment (HTA), Epidemiology, Biostatistics, and generation of Real World Evidence (RWE).Within HEVA Dupixent & Itepekimab, you will join a team of 10 business partners, all responsible to manage HEVA projects for the indications they are leading.Dupixent is the flagship of Sanofi Specialty Care life-changing immunology franchise. It is currently being launched worldwide in atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, Chronic Obstructive Pulmonary Disease (COPD), and prurigo nodularis and has the ambition of becoming the treatment of choice for all Type 2 inflammation diseases due to its innovative mode of action. The portfolio for this product includes over 10 possible indications that are currently being evaluated at various stages of development.Itepekimab is expected to bring new treatment options for patients with COPD or with Bronchiectasis, as well as other indications currently being evaluated.Main Responsibilities:This role will be responsible for the design and execution of Health Economic and Outcomes Research (HEOR) research in the forms of economic modeling, database analysis, observational research, Clinical Outcomes Assessment (COA) development and validation, systematic literature review, evidence synthesis, value dossier development, and other types of HEOR.This role will set the HEOR evidence generation priorities for Dupixent indications under development and incorporate them into broader Sanofi planning documents such as the integrated evidence generation plan (IEGP).This role will operate as part of a multi-functional global development team that is responsible for designing clinical research programs to meet the evidentiary standards of regulators, HTA organizations, reimbursement authorities, third-party payers, and other organizations that review evidence relevant to Sanofi medicines.About YouExperience : 5 years of experience in health economics, outcomes research, or a related field.Soft Skills :
Strong communication skills, both verbal and written, including presentation skills. Significant experience making presentations to senior management is preferred. Publication in peer-reviewed journals.Strong ability to partner with HEVA colleagues and other (i.e., non-HEOR) functional areas.Entrepreneurial, team spirit, and ability to develop creative solutions to complex problems.
Technical Skills :
Demonstrated experience in applying various HEOR methods. Understanding the principles of evidence-based medicine and clinical research.Knowledge of global HTA processes and guidelines; experience with HTA submissions preferred.Understanding of the legal and regulatory environment of the pharmaceutical industry, demonstrated integrity on work-related compliance considerations, and solid ethics.
Education : Advanced degree (PhD, MD, MS, MPH, or PharmD) in a scientific discipline.Languages : English fluent, both written and oral.Why Choose UsBring the miracles of science to life alongside a supportive, future-focused team.Discover endless opportunities to grow your talent and drive your career, whether it’s through a promotion or lateral move, at home or internationally.Enjoy a thoughtful, well-crafted rewards package that recognizes your contribution and amplifies your impact.Take good care of yourself and your family, with a wide range of health and wellbeing benefits including high-quality healthcare, prevention and wellness programs, and at least 14 weeks’ gender-neutral parental leave.Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
#J-18808-Ljbffr